ViewRay’s radiation therapy system is being developed to feature a patented combination of radiotherapy delivery and simultaneous magnetic resonance imaging (MRI).

The ViewRay system is being designed to provide continuous soft-tissue imaging during treatment, using MRI-guided radiotherapy which aids clinicians to view where the actual radiation dose is being delivered and adapt to changes in the patient’s anatomy.

JCCC clinical affairs director and UCLA Department of Radiation Oncology chair Michael Steinberg said the ViewRay system will enable researchers at UCLA to continue to meet their mission of fostering patient-centered care while pursuing better treatments and cures for cancer.

The ViewRay system is currently available only as a non-human use research system and is having pending 510(k) premarket notification review with the US Food and Drug Administration (FDA).